{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:44:54Z","timestamp":1761630294975},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1053\/hupa.2002.124014","type":"journal-article","created":{"date-parts":[[2003,2,11]],"date-time":"2003-02-11T13:03:54Z","timestamp":1044968634000},"page":"1001-1005","source":"Crossref","is-referenced-by-count":15,"title":["Lentigo maligna and superficial spreading melanoma are different in their in situ phase: An immunohistochemical study"],"prefix":"10.1053","volume":"33","author":[{"given":"Silviu","family":"Auslender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aviv","family":"Barzilai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juri","family":"Kopolovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Trau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/hupa.2002.124014_bib1","first-page":"654","article-title":"Benign pigmented lesions and malignant melanoma","author":"Elder","year":"1997"},{"key":"10.1053\/hupa.2002.124014_bib2","first-page":"1085","article-title":"Neoplasms: Cutaneous melanoma","author":"Barnhill","year":"1999"},{"key":"10.1053\/hupa.2002.124014_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0046-8177(80)80069-4","article-title":"Malignant melanoma: A unifying concept","volume":"11","author":"Ackerman","year":"1980","journal-title":"Hum Pathol"},{"key":"10.1053\/hupa.2002.124014_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0046-8177(86)80030-2","article-title":"A unifying concept of malignant melanoma: Biologic aspects","volume":"17","author":"Ackerman","year":"1986","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1053\/hupa.2002.124014_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000247648","article-title":"Malignant melanoma in southern Germany: Different predictive value of risk factors for melanoma subtypes","volume":"183","author":"Weiss","year":"1991","journal-title":"Dermatologica"},{"key":"10.1053\/hupa.2002.124014_bib6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/bjc.1996.168","article-title":"Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck","volume":"73","author":"Cox","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1053\/hupa.2002.124014_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01607148","article-title":"Proliferative activity of primary cutaneous melanocytic tumors","volume":"423","author":"Kuwata","year":"1993","journal-title":"Virchows Arch Pathol Anat Histopathol"},{"key":"10.1053\/hupa.2002.124014_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00372033","article-title":"Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index","volume":"284","author":"Tokuda","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"10.1053\/hupa.2002.124014_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/path.1711730409","article-title":"Dermal vascularity in lentigo maligna","volume":"173","author":"Trotter","year":"1994","journal-title":"J Pathol"},{"key":"10.1053\/hupa.2002.124014_bib10","article-title":"Melanoma in situ and tumor vascularity","author":"Barnhill","year":"1997"},{"key":"10.1053\/hupa.2002.124014_bib11","first-page":"510","article-title":"Extent of vascularization as a prognostic indicator in thin malignant melanomas","volume":"145","author":"Graham","year":"1994","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1053\/hupa.2002.124014_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0560.1995.tb01393.x","article-title":"Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen","volume":"22","author":"Guffey","year":"1995","journal-title":"J Cutan Pathol"},{"key":"10.1053\/hupa.2002.124014_bib13","first-page":"1049","article-title":"Tumor vascularity is not a prognostic factor for malignant melanoma of the skin","volume":"147","author":"Busam","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2002.124014_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1600-0560.1991.tb01542.x","article-title":"HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein","volume":"18","author":"Smoller","year":"1991","journal-title":"J Cutan Pathol"},{"key":"10.1053\/hupa.2002.124014_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000372-199113060-00004","article-title":"HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation","volume":"13","author":"Skelton","year":"1991","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1053\/hupa.2002.124014_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0560.1989.tb00010.x","article-title":"HMB45 recognizes stimulated melanocytes","volume":"16","author":"Smoller","year":"1989","journal-title":"J Cutan Pathol"},{"key":"10.1053\/hupa.2002.124014_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000372-199510000-00001","article-title":"Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma","volume":"17","author":"Collins","year":"1995","journal-title":"Am J Dermatopathol 1995"},{"key":"10.1053\/hupa.2002.124014_bib18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0560.1994.tb00278.x","article-title":"Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi","volume":"21","author":"Saenz-Santamaria","year":"1994","journal-title":"J Cutan Pathol"},{"key":"10.1053\/hupa.2002.124014_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.1994.tb02927.x","article-title":"Stable and strong expression of basic Fibroblast growth factor in naevus cell naevus contrast with aberrant expression in melanoma","volume":"130","author":"Ueda","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1053\/hupa.2002.124014_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/1523-1747.ep12874447","article-title":"Antigen dynamics in melanocytic and nevocytic melanoma oncogenesis","volume":"94","author":"Yamamura","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1053\/hupa.2002.124014_bib21","first-page":"329","article-title":"Differential expression of basic fibroblast growth factor in melanocytic lesions demonstrated by in situ hybridization","volume":"14","author":"Reed","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2002.124014_bib22","first-page":"161","article-title":"A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction","volume":"2","author":"Giorno","year":"1994","journal-title":"Diagn Immunol"},{"key":"10.1053\/hupa.2002.124014_bib23","first-page":"1131","article-title":"The use of avidin biotin interaction in Immunoenzymatic techniques","volume":"27","author":"Guesdon","year":"1979","journal-title":"J Histochem"},{"key":"10.1053\/hupa.2002.124014_bib24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1523-1747.ep12465203","article-title":"Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization","volume":"96","author":"Scott","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1053\/hupa.2002.124014_bib25","first-page":"177","article-title":"bFGF as an autocrine growth factor for human melanomas","volume":"3","author":"Halaban","year":"1988","journal-title":"Oncogene Res"},{"key":"10.1053\/hupa.2002.124014_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","article-title":"What is the evidence that tumors are angiogenesis dependent?","volume":"82","author":"Folkman","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/hupa.2002.124014_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other diseases","volume":"1","author":"Folkman","year":"1995","journal-title":"Nature Med"},{"key":"10.1053\/hupa.2002.124014_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.109.1.1","article-title":"Recent developments in the cell biology of basic fibroblast growth factor","volume":"109","author":"Rifkin","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1053\/hupa.2002.124014_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/hp.2000.6724","article-title":"Angiogeneis as a predictor of clinical outcome in cancer patients","volume":"31","author":"Weidner","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1053\/hupa.2002.124014_bib30","first-page":"317","article-title":"Tumor vascularity in prognosis","author":"Gasparini","year":"1999"},{"key":"10.1053\/hupa.2002.124014_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1523-1747.ep12608179","article-title":"Pagetoid premalignant melanosis and melanoma: Differentiation from Hutchinson's melanotic freckle","volume":"65","author":"Mishima","year":"1975","journal-title":"J Invsest Dermatol"},{"key":"10.1053\/hupa.2002.124014_bib32","first-page":"83","article-title":"The developmental biology of primary human malignant melanomas","volume":"2","author":"Clark","year":"1975","journal-title":"Semin Oncol"},{"key":"10.1053\/hupa.2002.124014_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00000372-199104000-00013","article-title":"The epidermal melanin unit in the pathophysiology of malignant melanoma","volume":"13","author":"Jimbow","year":"1991","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/hupa.2002.124014_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00557919","article-title":"Tyrosinase activity in three types of the malignant melanoma: Superficial spreading melanoma, lentigo maligna melanoma and nodular melanoma","volume":"252","author":"Haensch","year":"1975","journal-title":"Arch Dermatol Forsch"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817702001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817702001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T17:20:18Z","timestamp":1554398418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817702001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0046817702001028"],"URL":"https:\/\/doi.org\/10.1053\/hupa.2002.124014","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}